1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
LIWANLI Innovation Co., Ltd.

LIWANLI Innovation Co., Ltd.

3054.TW
LIWANLI Innovation Co., Ltd.TW flagTaiwan Stock Exchange
63.60
TWD
-0.70
- -
5.13BMarket Cap

Total Valuation

LIWANLI Innovation Co., Ltd. carries a market capitalization of 5.13B, placing it among publicly traded companies globally. Its enterprise value stands at 1.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5.13B
Enterprise Value1.65B

Share Statistics

LIWANLI Innovation Co., Ltd. currently has 80.65M shares outstanding.

Shares Outstanding80.65M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 21.46, and the price-to-book ratio stands at 2.50.

PE RatioN/A
PS Ratio21.46
PB Ratio2.50
P/TBV Ratio2.63
P/FCF Ratio-80.56
P/OCF Ratio-65.06

Enterprise Valuation

EV / Sales18.15
EV / EBITDAN/A
EV / EBITN/A
EV / FCF311.29

Financial Position

LIWANLI Innovation Co., Ltd. maintains a current ratio of 13.30, meaning it holds 13.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.02, indicating conservative leverage, while an interest coverage ratio of -60.68 demonstrates limited ability to service its debt obligations.

Current Ratio13.30
Quick Ratio10.69
Debt / Equity0.02
Debt / EBITDA0.00
Interest Coverage-60.68

Financial Efficiency

Return on Equity (ROE)-3.22
Return on Assets (ROA)-3.23
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.29

Taxes

Income Tax529,000.00
Effective Tax RateN/A

Stock Price Statistics

LIWANLI Innovation Co., Ltd.'s stock has gained approximately 172.37687% over the past 52 weeks. The 50-day moving average sits at 68.59, while the 200-day moving average is 44.48.

Beta (5Y)N/A
52-Week Price Change172.37687%
50-Day Moving Average68.59
200-Day Moving Average44.48
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, LIWANLI Innovation Co., Ltd. generated 91.02M in revenue and converted that into -25.86M in net income, yielding earnings per share of -0.32. EBITDA reached -39.14M, while operating income came in at -39.14M.

Revenue91.02M
Gross Profit24.07M
Operating Income-39.14M
Pretax Income-25.33M
Net Income-25.86M
EBITDA-39.14M
EBIT-39.14M
Earnings Per Share (EPS)-0.32

Balance Sheet

LIWANLI Innovation Co., Ltd. holds 300.97M in cash and equivalents against 121,000.00 in total debt, resulting in a net debt position of -200.34M. Total book value stands at 780.28M, with working capital of 346.46M providing operational flexibility.

Cash & Cash Equivalents300.97M
Total Debt121,000.00
Net Debt-200.34M
Equity (Book Value)780.28M
Book Value Per Share9.51
Working Capital346.46M

Cash Flow

LIWANLI Innovation Co., Ltd. produced -30.01M in operating cash flow over the past twelve months. After subtracting -5.77M in capital expenditures, free cash flow totaled -35.79M - equivalent to -0.44 per share.

Operating Cash Flow-30.01M
Capital Expenditures-5.77M
Free Cash Flow-35.79M
FCF Per Share-0.44

Margins

LIWANLI Innovation Co., Ltd. operates with a gross margin of 26.45, reflecting its pricing power and cost economics. The operating margin of -43.00 and net profit margin of -28.42 provide insight into operational efficiency.

Gross Margin26.45
Operating Margin-43.00
Pretax Margin-27.83
Profit Margin-28.42
EBITDA Margin-43.00

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.02
FCF Yield-1.24

Stock Splits

LIWANLI Innovation Co., Ltd.'s most recent stock split took place on September 13, 2018 with a 1000:743 split ratio.

Last Split Date9/13/2018
Split Ratio1000:743

Scores

LIWANLI Innovation Co., Ltd. posts an Altman Z-Score of 36.10, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score36.10